Effects of thromboxane synthetase inhibitors on aggregation of rabbit platelets

European Journal of Pharmacology
J NaitoM Tsuboshima

Abstract

Thromboxane (TX) synthetase activity was selectively inhibited by (E)-3-[4-(1-imidazolylmethyl)phenyl]-2-propenoic acid hydrochloride monohydrate (OKY-046) and sodium (E)-3-[4-(3-pyridylmethyl)phenyl]-2-methyl-propenoate (OKY-1581) (OKYs). Their IC50 for the rabbit platelet enzyme were found to be 11nM and 3nM respectively. Arachidonic acid (AA) or collagen induced platelet aggregation, and generated TXA 2 and prostaglandins (PGs) in rabbit platelets. OKYs inhibited platelet aggregation and TXA2 generation without affecting PGs generation, while aspirin inhibited platelet aggregation, and TXA2 and PGs generation. There was a parallel relation between the degree of inhibition of platelet aggregation and TXA2 generation by OKYs, but the inhibitory effects of aspirin on platelet aggregation was related to that on both TXA2 and PGs generation. However, OKYs and aspirin did not inhibit ADP-induced platelet aggregation which did not involve the generation of TXA2 and PGs. These results suggested that TXA2 generation is related to platelet aggregation induced by AA or collagen, and that the inhibitory effect of OKYs on platelet aggregation is due to the inhibition of TX synthetase.

References

Mar 15, 1979·Biochemical and Biophysical Research Communications·K WatanabeO Hayaishi
Apr 1, 1977·Proceedings of the National Academy of Sciences of the United States of America·P NeedlemanM Minkes
Feb 1, 1979·The Journal of Clinical Investigation·P NeedlemanA Raz
Apr 1, 1977·Prostaglandins·S MoncadaP Needleman
Jan 13, 1978·Biochemical and Biophysical Research Communications·H H Tai, B Yuan
Nov 1, 1976·The Journal of Clinical Investigation·J B SmithM J Silver
Apr 1, 1975·Proceedings of the National Academy of Sciences of the United States of America·C MalmstenB Samuelsson
Aug 1, 1975·Proceedings of the National Academy of Sciences of the United States of America·M HambergB Samuelsson
Feb 1, 1974·Proceedings of the National Academy of Sciences of the United States of America·M HambergB Samuelsson
Mar 15, 1974·Science·M J SilverJ B Smith
Jun 23, 1971·Nature: New Biology·J B Smith, A L Willis
Feb 1, 1981·The Journal of Clinical Investigation·M R BuchananJ Hirsch
Sep 1, 1980·Archives of Biochemistry and Biophysics·H H TaiN Lee

❮ Previous
Next ❯

Citations

Dec 2, 1986·European Journal of Pharmacology·Y HoriK Tanaka
May 27, 1992·European Journal of Pharmacology·C D SommersD W Snyder
Jan 25, 1996·European Journal of Pharmacology·Y NasuharaY Kawakami
Feb 1, 1986·Prostaglandins, Leukotrienes, and Medicine·T SugiyamaH Uchino
Jan 1, 1989·Comparative Biochemistry and Physiology. C, Comparative Pharmacology and Toxicology·G S Bondy, P A Gentry
Jun 5, 2002·European Journal of Pharmacology·Carola BuccellatiSimonetta Nicosia
Aug 7, 2002·European Journal of Pharmacology·Yasuko KarasawaHiroaki Araki
Jan 1, 1986·Journal of the American College of Cardiology·Y YuiC Kawai
Mar 1, 1991·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·M FujimuraT Matsuda
Apr 3, 1998·Respirology : Official Journal of the Asian Pacific Society of Respirology·T NagataM Omata
May 31, 2002·Chemical & Pharmaceutical Bulletin·Shigeki SanoYoshimitsu Nagao
Jul 27, 2010·Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association·Yasumasa YamamotoRyo Oohara
Jun 11, 2002·Prostaglandins, Leukotrienes, and Essential Fatty Acids·Shigeharu MyouShinji Nakao
Oct 1, 1987·Thrombosis Research·L MassadR G Boulu
Jul 26, 2003·Stroke; a Journal of Cerebral Circulation·Sanne M Dorhout MeesJan van Gijn
Jul 21, 1998·The Journal of Asthma : Official Journal of the Association for the Care of Asthma·H KunitohT Nakagawa
Sep 7, 1999·Hypertension in Pregnancy : Official Journal of the International Society for the Study of Hypertension in Pregnancy·H SekiK Satoh
Jan 1, 1991·The Journal of Asthma : Official Journal of the Association for the Care of Asthma·M Hoshino, Y Fukushima
Jan 1, 1989·The Journal of Asthma : Official Journal of the Association for the Care of Asthma·M FujimuraT Matsuda
Mar 1, 1997·The Journal of International Medical Research·H KatoI Saito
Jan 1, 1991·The Journal of Asthma : Official Journal of the Association for the Care of Asthma·M FujimuraT Matsuda
Jan 1, 1988·The Journal of Asthma : Official Journal of the Association for the Care of Asthma·I IwamotoS Yoshida

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.